- Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer
-
Jung YD, Lee SB, Jung YW, Song JS, Woo IS
- KMID: 2411496
- Korean J Intern Med.
- 2017 Sep;32(5):923-925.
- doi: 10.3904/kjim.2015.042
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma
-
Youk J, Park H, Jin KN, Moon HJ, Yang MS, Kim KH, Kim JS
- KMID: 2379490
- Korean J Intern Med.
- 2017 May;32(3):563-565.
- doi: 10.3904/kjim.2015.250
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
-
Kim KH, Song SY, Lim KH, Han SS, Kim SH, Cho JH, Park CW, Lee S, Lee HY
- KMID: 2167611
- Cancer Res Treat.
- 2013 Mar;45(1):74-77.
Pemetrexed is approved as a first-line treatment for advanced non-squamous non-small cell lung cancer (NSCLC) with cisplatin and as a single agent for second-line treatment or for patients who show... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin
-
Kim JS, Lim SY, Hwang J, Kang EJ, Choi YJ
- KMID: 2390319
- J Korean Med Sci.
- 2017 Nov;32(11):1879-1884.
- doi: 10.3346/jkms.2017.32.11.1879
Primary pericardial malignant mesothelioma (PPM) is a very rare malignancy, with an incidence of less than 0.002% and represents less than 5% of all mesotheliomas. The cause of pericardial mesothelioma... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Pemetrexed in Advanced Non-Small Cell Lung Carcinoma
-
Lee GJ, Jung MH, Jang TW, Ok CH, Jung HJ
- KMID: 2319213
- Tuberc Respir Dis.
- 2009 Aug;67(2):121-126.
BACKGROUND: Pemetrexed has been prescribed newly as a second line chemotherapy in advanced non-small cell lung carcinoma (NSCLC). The aim of study was to determine the efficacy and toxicity of... -
- CITED
-
- Close
- SHARE
-
- Close
- Dramatic Tumor Response to 2nd-line Pemetrexed/Cisplatin Combination Chemotherapy in Patient with Malignant Pleural Mesothelioma.
-
Lee SM, Ko SY, Seo TH, Lee JH, Choi SO, Lee JG, Kim WS, Lee TH, Yoo GH, Lee KY
- KMID: 2318948
- Tuberc Respir Dis.
- 2007 May;62(5):432-436.
Malignant pleural mesothelioma (MPM) is a rare tumor that is difficult to clearly distinguish from an adenocarcinoma but usually has a poor prognosis. Numerous cytotoxic agents have been used in... -
- CITED
-
- Close
- SHARE
-
- Close
- Pemetrexed Continuation Maintenance versus Conventional Platinum-Based Doublet Chemotherapy in EGFR-Negative Lung Adenocarcinoma: Retrospective Analysis
-
Paik SS, Hwang IK, Park MJ, Lee SH
- KMID: 2420603
- Tuberc Respir Dis.
- 2018 Apr;81(2):148-155.
- doi: 10.4046/trd.2017.0090
BACKGROUND: Although targeted therapy and immuno-oncology have shifted the treatment paradigm for lung cancer, platinum-based combination is still the standard of care for advanced non-small cell lung cancer (NSCLC). Pemetrexed... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Pemetrexed in Relapsed Non-Small Cell Lung Cancer and Thymidylate Synthase Expression
-
Park CK, Kim KS, Oh IJ, Tseden-Ish M, Choi YD, Kwon YS, Kim YI, Lim SC, Kim YC
- KMID: 2319223
- Tuberc Respir Dis.
- 2009 Sep;67(3):191-198.
BACKGROUND: Pemetrexed, a multi-targeted antifolate has been used as a second line treatment against non-small cell lung cancer (NSCLC). We aimed to clarify the efficacy and survival according to line... -
- CITED
-
- Close
- SHARE
-
- Close
- Chemotherapy in Advanced Urothelial Carcinoma
-
Ha YS, Kim TH
- KMID: 2361563
- Korean J Urol Oncol.
- 2016 Aug;14(2):47-53.
- doi: 10.22465/kjuo.2016.14.2.47
Despite recent advances in the management of a wide variety of solid tumors, the outcomes for patients with advanced urothelial carcinoma remain relatively poor. Cisplatin-based combination chemotherapy remains the standard... -
- CITED
-
- Close
- SHARE
-
- Close
- Setting time of MTA
-
Hwang YC
- KMID: 2316875
- Restor Dent Endod.
- 2014 Feb;39(1):78-78.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of erlotinib, gefitinib, or pemetrexed in patients with non-squamous, non-small-cell lung cancer
-
Yoon LY, Yang MY, Yun J, Kim HJ, Kim HJ, Kim KH, Kim SH, Lee SC, Kim CK, Lee NS, Park SK, Lee KT, Won JH, Park HS, Hong DS
- KMID: 2259342
- Korean J Med.
- 2010 Oct;79(4):394-403.
BACKGROUND/AIMS: This study compared the clinical benefits of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) with pemetrexed to identify the clinical parameters that correlated with response. METHODS: A retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- KRAS Gâ‚â‚‚C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
-
Park S, Kim JY, Lee SH, Suh B, Keam B, Kim TM, Kim DW, Heo DS
- KMID: 2379482
- Korean J Intern Med.
- 2017 May;32(3):514-522.
- doi: 10.3904/kjim.2015.299
BACKGROUND/AIMS: The predictive and prognostic value of KRAS mutation and its type of mutations in non-small cell lung cancer (NSCLC) are controversial. This clinical study was designed to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
-
Jo J, Kim SH, Kim YJ, Lee J, Kim M, Keam B, Kim TM, Kim DW, Heo DS, Chung JH, Jeon YK, Lee JS
- KMID: 2418782
- Yonsei Med J.
- 2018 Mar;59(2):202-210.
- doi: 10.3349/ymj.2018.59.2.202
PURPOSE: Previous retrospective studies suggest that anaplastic lymphoma kinase (ALK) mutation-positive (ALK+) non-small cell lung cancer (NSCLC) patients are sensitive to pemetrexed. To determine its efficacy, we retrospectively evaluated clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- One-visit Apexification Using MTA and Reattachment of a Crown-root Fractured Tooth with Severe Coronal Damage: A Case Report
-
Park Y, Lee J, Ra J
- KMID: 2431345
- J Korean Acad Pediatr Dent.
- 2018 Nov;45(4):521-527.
- doi: 10.5933/JKAPD.2018.45.4.521
In dental trauma, reattachment of the original tooth fragment improves the reproduction of original tooth shape, texture, color, and radiolucency; thus, it provides good aesthetics. A 9-year-old boy was referred due... -
- CITED
-
- Close
- SHARE
-
- Close
- A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
-
Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, Cho EK, Choi YH, Kim HR, Kim HG, Ahn HJ, Lee HY, Yun HJ, Kang JH, Jeong J, Choi MY, Jung SH, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ
- KMID: 2464417
- Cancer Res Treat.
- 2019 Apr;51(2):718-726.
- doi: 10.4143/crt.2018.324
PURPOSE: The optimal cytotoxic regimens have not been established for patients with non-small cell lung cancer (NSCLC) who develop disease progression on first-line epidermal growth factor receptor tyrosine kinase inhibitor... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative evaluation of the bond strength of self-adhering and bulk-fill flowable composites to MTA Plus, Dycal, Biodentine, and TheraCal: an in vitro study
-
Raina A, Sawhny A, Paul S, Nandamuri
- KMID: 2470345
- Restor Dent Endod.
- 2020 Feb;45(1):e10.
- doi: 10.5395/rde.2020.45.e10
OBJECTIVES: This study aimed to compare the shear bond strength (SBS) of a self-adhering flowable composite (Dyad Flow) and a bulk-fill flowable composite (Smart Dentin Replacement [SDR]) to several pulp-capping... -
- CITED
-
- Close
- SHARE
-
- Close
- Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
-
Kang JH, Ahn MJ, Kim DW, Cho EK, Kim JH, Shin SW, Wang X, Kim JS, Orlando M, Park K
- KMID: 2454321
- Cancer Res Treat.
- 2016 Apr;48(2):458-464.
- doi: 10.4143/crt.2015.135
PURPOSE: We recently reported on a randomized, open-label, phase 3 trial comparing pemetrexed-cisplatin chemotherapy followed by gefitinib maintenance therapy (PC/G) with gefitinib monotherapy in patients with non-small cell lung cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Regenerative Endodontic Procedure in Korean Children and Adolescents: A Case Report
-
An SY, Kim JK, Shim YS
- KMID: 2360679
- J Dent Hyg Sci.
- 2016 Aug;16(4):317-322.
- doi: 10.17135/jdhs.2016.16.4.317
Mineral trioxide aggregate (MTA) is widely used in endodontic therapy as a pulp-capping material, root or furcal perforation repair material, and for apexification and obturation of the root canal system.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of various root canal sealers on tooth discoloration and internal bleaching
-
Kim YS, Choi SH, Youn KE, Jang JH, Chang HS, Hwang YC, Hwang IN, Oh WM, Lee BN
- KMID: 2448019
- Korean J Dent Mater.
- 2019 Mar;46(1):1-10.
- doi: 10.14815/kjdm.2019.46.1.1
There are several causes of tooth discoloration following root canal treatment. In this study, we evaluated the effects of sealers on tooth discoloration and internal bleaching. Twenty-four teeth were divided... -
- CITED
-
- Close
- SHARE
-
- Close
- Discoloration and radiopacity of white mineral trioxide aggregate with various radiopacifiers
-
Kwon JS, Kim YJ, Park IS
- KMID: 2463586
- Korean J Dent Mater.
- 2019 Sep;46(3):131-138.
- doi: 10.14815/kjdm.2019.46.3.131
The use of the mineral trioxide aggregate (MTA) has been expanded as the material can be applied on various treatment of endodontic care, which also has many advantages including bioactivity.... -
- CITED
-
- Close
- SHARE
-
- Close
